Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Recombinant Protein / Other Proteins

Recombinant Human ENTR1 Protein, N-His-SUMO

Catalog #:   YHN30201 Specific References (12) DATASHEET
Applications: ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress
Expression system: E. coli
Accession: Q96C92
Protein length: Glu314-Gln382
Overview

Catalog No.

YHN30201

Expression system

E. coli

Species

Homo sapiens (Human)

Protein length

Glu314-Gln382

Predicted molecular weight

20.17 kDa

Nature

Recombinant

Endotoxin level

Please contact with the lab for this information.

Purity

>90% as determined by SDS-PAGE.

Accession

Q96C92

Applications

ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress

Form

Lyophilized

Storage buffer

Lyophilized from a solution in PBS pH 7.4, 0.02% NLS, 1mM EDTA, 4% Trehalose, 1% Mannitol.

Reconstitution

Reconstitute in sterile water for a stock solution. A copy of datasheet will be provided with the products, please refer to it for details.

Shipping

In general, proteins are provided as lyophilized powder/frozen liquid. They are shipped out with dry ice/blue ice unless customers require otherwise.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.

Alternative Names

ENTR1, Endosome-associated-trafficking regulator 1, Antigen NY-CO-3, SDCCAG3, Serologically defined colon cancer antigen 3

Data Image
  • SDS-PAGE
    SDS-PAGE for Recombinant Human ENTR1 protein
References

ENTR1 affects the progression of colon cancer by regulating energy metabolism under the influence of glycolysis., PMID:40462015

ENTR1 regulates periodontitis by modulating macrophage M1 polarization via AMPK activation., PMID:40054733

AN698/40746067 suppresses bone marrow adiposity to ameliorate hyperlipidemia-induced osteoporosis through targeted inhibition of ENTR1., PMID:38810405

Proteomic Analyses in Diverse Populations Improved Risk Prediction and Identified New Drug Targets for Type 2 Diabetes., PMID:38623619

Endosome associated trafficking regulator 1 promotes tumor growth and invasion of glioblastoma multiforme via inhibiting TNF signaling pathway., PMID:38191954

Functional enrichment analysis of LYSET and identification of related hub gene signatures as novel biomarkers to predict prognosis and immune infiltration status of clear cell renal cell carcinoma., PMID:37740762

Expression Quantitative Trait Loci in Equine Skeletal Muscle Reveals Heritable Variation in Metabolism and the Training Responsive Transcriptome., PMID:31850069

Apoptotic signalling targets the post-endocytic sorting machinery of the death receptor Fas/CD95., PMID:31308371

The serologically defined colon cancer antigen-3 (SDCCAG3) is involved in the regulation of ciliogenesis., PMID:27767179

Retromer binding to FAM21 and the WASH complex is perturbed by the Parkinson disease-linked VPS35(D620N) mutation., PMID:24980502

The serologically defined colon cancer antigen-3 interacts with the protein tyrosine phosphatase PTPN13 and is involved in the regulation of cytokinesis., PMID:23108400

Serologically defined colon cancer antigen 3 is necessary for the presentation of TNF receptor 1 on cell surface., PMID:16332174

Datasheet
$ 313
Product specifications
100 μg 313 1 mg 1629

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Recombinant Human ENTR1 Protein, N-His-SUMO [YHN30201]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only